Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

The effect of long-term release of Shh from implanted biodegradable microspheres on recovery from spinal cord injury in mice.

Authors: Lowry, N  Goderie, SK  Lederman, P  Charniga, C  Gooch, MR  Gracey, KD  Banerjee, A  Punyani, S  Silver, J  Kane, RS  Stern, JH  Temple, S 
Citation: Lowry N, etal., Biomaterials. 2012 Jan 11.
Pubmed: (View Article at PubMed) PMID:22243800
DOI: Full-text: DOI:10.1016/j.biomaterials.2011.12.048

After spinal cord injury (SCI), loss of cells and damage to ascending and descending tracts can result in paralysis. Current treatments for SCI are based on patient stabilization, and much-needed regenerative therapies are still under development. To activate and instruct stem and progenitor cells or injured tissue to aid SCI repair, it is important to modify the injury environment for a protracted period, to allow time for cell activation, proliferation and appropriate fate differentiation. Shh plays a critical role in spinal cord formation, being involved in multiple processes: it promotes production of motor neurons and oligodendrocytes from ventral cord progenitor cells and serves as an axon guidance molecule. Hence Shh is a candidate pleiotropic beneficial environmental factor for spinal cord regeneration. Here we show that administration of biodegradable microspheres that provide sustained, controlled delivery of Shh resulted in significant functional improvement in two different mouse models of SCI: contusion and dorsal hemioversection. The mechanism is multifactorial, involving increased proliferation of endogenous NG2+ oligodendrocyte lineage cells, decreased astrocytic scar formation and increased sprouting and growth of corticospinal (CST) and raphespinal tract (RST) fibers. Thus, long-term administration of Shh is a potential valuable therapeutic intervention for SCI.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 5686844
Created: 2012-01-27
Species: All species
Last Modified: 2012-01-27
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.